Osteoporosis
Conditions
Interventions
Control group:Supplement with calcium, vitamin D and anti-osteoporosis treatment, and conduct routine basic knowledge education
Experimental group:Supplement with calcium, vitamin D and anti-osteoporosis treatment, and incorporate into the MMC platform for management.
Sponsors
Hefei First People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Bone density indicates osteoporosis and bone mass reduction; 2.People who can receive anti-osteoporosis drug treatment;
Exclusion criteria
Exclusion criteria: 1. Individuals with bone metabolism disorders other than osteoporosis: a. Various metabolic bone diseases, such as osteomalacia, osteogenesis imperfecta, Paget's disease, etc.; b. Cushing's syndrome; c. Hyperprolactinemia; d. Others; 2. Those who have had or are currently suffering from osteomyelitis of the jaw or jaw necrosis; dental surgery or oral surgery wounds that have not healed; acute dental or jaw diseases requiring oral surgery; those who have planned to undergo invasive dental surgery during the study period; 3. Those who have had malignant tumors within the past 5 years, or have bone metastases, but with tumors that are expected to heal after treatment (such as complete resection of in situ basal cell or squamous cell carcinoma of the skin, cervical cancer or breast ductal carcinoma, etc.) are excluded. 4. Those with severe heart, liver, or kidney dysfunction or mental disorders who cannot cooperate with the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone density; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood calcium;Bone turnover markers; | — |
Countries
China
Contacts
Public ContactDengpan Yao
The First People's Hospital of Hefei City
Outcome results
None listed